A detailed history of Royal Bank Of Canada transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 14,583 shares of TXG stock, worth $231,286. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,583
Previous 26,102 44.13%
Holding current value
$231,286
Previous $979,000 71.09%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$19.45 - $37.37 $224,044 - $430,465
-11,519 Reduced 44.13%
14,583 $283,000
Q1 2024

May 15, 2024

BUY
$36.08 - $54.3 $83,886 - $126,247
2,325 Added 9.78%
26,102 $979,000
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $382,153 - $640,819
11,135 Added 88.08%
23,777 $1.33 Million
Q3 2023

Nov 14, 2023

BUY
$40.86 - $62.98 $65,130 - $100,390
1,594 Added 14.43%
12,642 $521,000
Q2 2023

Aug 14, 2023

SELL
$50.96 - $58.72 $85,612 - $98,649
-1,680 Reduced 13.2%
11,048 $616,000
Q1 2023

May 15, 2023

SELL
$35.33 - $55.79 $464,306 - $733,192
-13,142 Reduced 50.8%
12,728 $710,000
Q4 2022

Feb 14, 2023

SELL
$24.4 - $41.3 $188,782 - $319,538
-7,737 Reduced 23.02%
25,870 $942,000
Q3 2022

Nov 14, 2022

SELL
$28.48 - $52.59 $514,064 - $949,249
-18,050 Reduced 34.94%
33,607 $956,000
Q2 2022

Aug 15, 2022

BUY
$36.95 - $82.41 $173,960 - $387,986
4,708 Added 10.03%
51,657 $2.34 Million
Q1 2022

May 16, 2022

SELL
$55.7 - $145.79 $130,672 - $342,023
-2,346 Reduced 4.76%
46,949 $3.57 Million
Q4 2021

Feb 14, 2022

BUY
$135.05 - $182.59 $2.34 Million - $3.17 Million
17,341 Added 54.27%
49,295 $7.34 Million
Q3 2021

Nov 15, 2021

BUY
$145.58 - $192.14 $148,346 - $195,790
1,019 Added 3.29%
31,954 $4.65 Million
Q2 2021

Aug 16, 2021

BUY
$134.22 - $202.37 $4.15 Million - $6.26 Million
30,935 New
30,935 $6.06 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.51B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.